Critically Ill | Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

Critically Ill research study

What is the primary objective of this study?

Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and decrease the quantity of heparin during continuous renal replacement therapy in critically ill.

Who is eligible to participate?

Inclusion Criteria: - age> 18 years old - admitted to ICU and need CRRT - anticipated survival time >72h Exclusion Criteria: - allergy to hemofilter or heparin - heparin associated thrombocytopenia - pregnancy or lactation - using other anticoagulate drugs

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Critically Ill

Acute Kidney Injury

Septic Shock

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Device:AN 69 ST hemofilter

Device:AN 69 hemofilter

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

AN 69 ST hemofilterUse AN 69 ST hemofilter during CRRT

AN 69 hemofilterUse AN 69 hemofilter during CRRT

Study Status

Unknown status

Start Date: January 2012

Completed Date:

Phase: N/A

Type: Interventional


Primary Outcome: The using time of hemofilters

Secondary Outcome: activated partial thromboplastin time

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: Zhongda Hospital


More information:

Discuss Malaise